BioGenerator Wins $300K Federal Grant to Build Companies in St. Louis

By on October 1, 2017

From EQ:  BioGenerator, the investment arm of BioSTL, has won a $300,000 grant from the U.S. Department of Commerce to capitalize on its retooled investment strategy. That strategy is focused around quickly scaling companies to attract downstream investors, while also building new companies with a faster timeline to sales of commercial products or services.

To date, BioGenerator has invested $17.9 million into 71 companies. These investments attracted more than $530 million in additional capital from outside funders. BioGenerator’s ability to generate that 30x leverage places it among the leading early-stage investors in the country.

“Our team will work hand-in-hand with burgeoning St. Louis companies to ensure that they reach milestones that make them successful and accelerate how quickly they can compete for more traditional financing,” said Eric Gulve, President of BioGenerator. “Coupled with our own investment money, this grant will help us further drive high-growth-potential companies, boosting their research and results, thus creating more opportunities and jobs for St. Louisans.”

Read more.


About Dede Hance